UnitedHealthcare has a two-level appeal process: Level 1 appeal (internal): Submit within 180 days of denial Include provider letter explaining medical necessity Include supporting clinical documentation (labs, medication trial records, weight logs) Decision within 30 days for standard appeals, 72 hours for urgent appeals Approval rate on Level 1 appeals: 22% Level 2 appeal (external review): Available if Level 1 denied Reviewed by independent third party, not UnitedHealthcare Must file within 60 days of Level 1 denial Decision is binding on UnitedHealthcare Approval rate on Level 2 appeals: 38% The appeal success rate is higher for diabetes indication (45% combined Level 1 + Level 2) than weight-loss indication (28% combined)
Such an increase can be drastic up to hundreds of thousands of dollars or more just for these medications
Skipping meals or eating too little GLP-1s help with portion control, but you still need nutrients and fuel to stay healthy and energized
If your focus is detoxification, skin health, or reducing stress-related damage, glutathione may be more suitable
For those who struggle with protein consumption, protein supplements may also be a good option
Popular GLP-1 medications Some of the most well-known GLP-1 drugs include: Semaglutide: Sold under the names Ozempic and Wegovy by manufacturer Novo Nordisk Tirzepatide: Technically a dual GLP-1/GIP agonist, sold as Mounjaro and Zepbound, developed by Eli Lilly Liraglutide: Sold as Saxenda and Victoza (and generically), also manufactured by Novo Nordisk Forms of GLP-1 medications and FDA approval Injections : The name-brand medications listed above have all been FDA approved , but only in injectable form
